News
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.
Once users stop taking Mounjaro, their appetite is no longer suppressed, and there's a decent chance that they will revert back to old eating habits and put the weight back on, but there are also ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...
Simone Biles was seen in an advertisement for the GLP-1 diabetes drug Mounjaro alongside her mother, Nellie Biles.
15h
Flow Space on MSNSemaglutide Is Not the Best GLP-1 Drug You Can Take for Losing Weight FastSemaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...
20h
Verywell Health on MSNWhat Happens to Your Hair When You Take Weight-Loss Medications?Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results